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AMP-activated protein kinase (AMPK) is a conserved cellular fuel gauge previously implicated in
aging. In this issue, Lu et al. (2011) describe how age-related deacetylation of Sip2, a subunit of
the AMPK homolog in yeast, acts as a life span clock that can be wound backward or forward to
modulate longevity.From the age of Hippocrates, medicine
has long appreciated the importance of
preserving physiological homeostasis for
a healthy life. Indeed, the ancient Greeks
believed that a failure to maintain proper
balance between the four ‘‘humors,’’ or
liquids of the blood, was at the root of
human disease. Despite modern medi-
cine’s departure from humorism, the idea
that a cellular collapse in homeostasis
might underlie late onset diseases still
prevails. In this issue, Lu and colleagues
(Lu et al., 2011) present new data sup-
porting this ancient theory.
One fundamental cellular process re-
quiring tight homeostatic control during
aging is the balance between energy
generation and usage. In eukaryotes, a
key orchestrator of energy homeostasis
is AMPK, a serine/threonine kinase that
functions as a cellular energy sensor, acti-
vating catabolic processes to generate
ATP when energy levels are low while
simultaneously shutting down energy re-
quiring anabolic processes (Steinberg
and Kemp, 2009). The importance of
maintaining energy homeostasis through-
out life is underscored by the fact that
AMPK activity mediates life span in yeast,
worms, and flies. Uncovering a novel
mode of AMPK regulation in yeast, the
work by Lu et al. (2011) demonstrates that
progressive deacetylation of the AMPK
subunit Sip2 with age limits replicative life
span (defined as the number of times that
a single cell can divide) and that blocking
this change can slow aging.
The S. cerevisiae homolog of AMPK is
a heterotrimeric complex made up of
both a single a and g subunit, Snf1 and
Snf4 (sucrose nonfermenting), respec-tively, and one of three alternative
b subunits, Snf-interacting proteins (Sip)
1 and 2 and Gal83. Previous work has
shown that one b subunit in particular,
Sip2, plays a pivotal role in regulating
Snf1 activity with age (Ashrafi et al.,
2000). Sip2 inhibits the Snf1 complex by
sequestering Snf4 to the plasma mem-
brane. As cells age, Sip2 shuttles from
the plasma membrane to the cytosol,
progressively activating Snf1, resulting in
limited replicative life span. In the current
study, Lu et al. (2011) expand upon this
model to demonstrate that the acetylation
status of Sip2 is the critical mechanism
controlling Snf1 activity during aging.
Using tandem mass spectrometry, the
authors identify residues on Sip2 that
become progressively deacetylated in
older cells. This change in Sip2 acetylation
status seems causal in yeast replicative
aging, as Sip2 mutants that are always
deacetylated are short lived, whereas
Sip2 acetylation mimics live longer than
wild-type cells. Acetylation of Sip2 is
antagonistically regulated by the acetyl
transferase NuA4 and the deacetylase
Rpd3. Strikingly, Sip2 is the primary
longevity target of these enzymes; the
short life span of NuA4mutants is rescued
by Sip2 acetylation mimics, whereas the
extended life span of RPD3 mutants is
not further enhanced by increasing Sip2
acetylation. Together, these data suggest
that progressive deacetylation of Sip2
with time acts analogously to a longevity
clock that marks the age of the cells
and that interventions that drive acetyla-
tion or deacetylation of Sip2 can wind
the clock backward or forward, respec-
tively (Figure 1).Cell 146, SeThe mechanism by which the ticking of
this clock modulates cellular aging hinges
upon changes to Snf1 activity; as Sip2
becomes deacetylated with age, it loses
its ability to bind to Snf1 and repress the
complex. The resulting hyperactivation
of Snf1 leads to accumulation of the
stress-associated disaccharide treha-
lose, increased sensitivity to reactive ox-
ygen species, and limited life span—all
of which can be reversed by preserving
Sip2 acetylation status.
Changes to energy balance can have
profound physiological consequences
for the cell and have been shown previ-
ously to even alter the rate at which organ-
isms age. In species ranging from yeast
to primates, reducing available energy
increases organismal life span and pro-
tects against age-related diseases (Fon-
tana et al., 2010). Given its role in sensing
energy status, AMPK has therefore been
suggested to be a central mediator of
life span by dietary restriction. However,
in the study by Lu et al., the effects of
Sip2 acetylation on life span appear to
be independent of glucose availability of
the cell, and as such, the authors suggest
a role for Sip2 in determining the intrinsic
rate at which cells age, rather than the
ability to change that rate in response to
extrinsic factors. Interestingly, however,
both the intrinsic aging pathway de-
scribed by Lu et al. and the dietary restric-
tion-induced ‘‘extrinsic’’ pathway, regu-
lated by target of rapamycin 1 (TORC1) in
yeast, converge upon a shared down-
stream mediator, Sch9.
Sch9, itself a kinase, has homology to
Akt and functions analogously to mam-
malian S6 kinase. No stranger to theptember 16, 2011 ª2011 Elsevier Inc. 859
Figure 1. The Deactylation Life Span Clock
Deacetylation of the yeast AMPK subunit Sip2 with time acts as an intrinsic
aging clock, which drives cellular aging by a mechanism that is distinct from
the effects of dietary restriction. As yeast cells age, Sip2 becomes deacety-
lated, removing its repression of the AMPK homolog Snf1 and inducing cellular
aging via Sch9 phosphorylation. The life span clock can be wound backward
via Sip2 acetylation mimics or by inactivating the deacetylase Rpd3,
promoting longevity. These findings describe a novel level of AMPK regulation
with age and pose new questions about the links between energy homeostasis
and longevity and the potential of AMPK as a target to treat age-related
disease.aging field, inhibition of S6K
increases longevity in yeast,
worms, flies, and mammals
(Fontana et al., 2010).
Although Sch9 is perhaps
best known as a substrate for
TORC1, Lu et al. show that
the Snf1 complex can phos-
phorylate Sch9 independently
and that the short life span of
Sip2 acetylation mutants can
be rescued by deleting SCH9.
Sch9 is known to regulate
many cellular processes that
influence aging, including
autophagy and translation,
both central nodes in the
maintenance of cellular ho-
meostasis. The data pre-
sented by Lu et al. indicate
that, at least in yeast, Sch9
may be crucial for modulating
both intrinsic and extrinsic
aging, emphasizing the im-
portance of identifying the
downstream targets of Sch9-
mediated longevity.
The study by Lu and col-
leagues describes a novel
role foracetylationofanonhis-tone protein in mediating yeast life span
and provides an exciting link between
AMPK and S6K that may be critical
for mediating intrinsic cellular aging.
However, it also leaves some questions
unanswered. Foremost of these is the
extent to which this mechanism will trans-
late to higher organisms. Indeed, several
lines of evidence suggest that, despite
a high degree of conservation between
Snf1 and AMPK, there has been diver-
gence in their regulation. Whereas mam-
malian AMPK senses cellular energy
status via nucleotide binding to its g
subunit, this does not seem to be the
case for Snf1 (Steinberg and Kemp,
2009). Furthermore, unlike yeast, mam-
mals only have two AMPK b subunits,
and as yet, neither has been shown to860 Cell 146, September 16, 2011 ª2011 ElsantagonizeAMPK. Finally, little is currently
known about the relationship between
AMPKandS6K inmammals, but in at least
one cancer model, stimulation of AMPK
results in reduced, rather than enhanced,
phosphorylation of S6K (Taliaferro-Smith
et al., 2009).
The effects of yeast AMPK activity
on life span also contrast with what is
known inmulticellular organisms. In yeast,
inhibiting AMPK activity is beneficial
for life span, whereas inhibiting AMPK
shortens life span in both C. elegans
(Apfeld et al., 2004) and Drosophila
melanogaster (Tohyama and Yamaguchi,
2010). Conversely, activating AMPK
increases C. elegans life span (Apfeld
et al., 2004), dependent upondownstream
transcriptional regulators FOXO (Greerevier Inc.et al., 2007) and CRTC-1
(Mair et al., 2011). However,
as is the case in yeast (Zhang
et al., 2010), different hetero-
trimeric combinations of
AMPK have alternating func-
tions in mammals (Steinberg
and Kemp, 2009), and which
of these might be involved in
life span modulation is yet to
be investigated.
If the work from Lu et al. in
yeast does translate to mam-
mals, perhaps dysregulation
of this ancestral energy ho-
meostasis control mechanism
represents a conserved basis
for aging, the prevention of
which will take us one step
closer to the elixir of life.
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